Li Y, Tong Z, Yang Y, Wang Y, Wen L, Li Y
BMC Cancer. 2025; 25(1):478.
PMID: 40089661
DOI: 10.1186/s12885-025-13883-w.
Rostami Ravari N, Sadri F, Mahdiabadi M, Mohammadi Y, Ourang Z, Rezaei Z
Front Cell Dev Biol. 2025; 13:1522873.
PMID: 40078365
PMC: 11897296.
DOI: 10.3389/fcell.2025.1522873.
Smolarz B, Lukasiewicz H, Samulak D, Piekarska E, Kolacinski R, Romanowicz H
Int J Mol Sci. 2025; 26(5).
PMID: 40076671
PMC: 11900952.
DOI: 10.3390/ijms26052049.
Hosseini S, Hajianfar G, Hall B, Servaes S, Rosa-Neto P, Ghafarian P
Cancer Imaging. 2025; 25(1):33.
PMID: 40075547
PMC: 11905451.
DOI: 10.1186/s40644-025-00857-1.
Xu C, Liu M, Li Y, Peng X, Zhou W, Zhang W
Discov Oncol. 2025; 16(1):270.
PMID: 40050481
PMC: 11885760.
DOI: 10.1007/s12672-025-01986-6.
circDENND4C serves as a sponge for miR-200b to drive non-small cell lung cancer advancement by regulating MMP-9 expression.
Lv Y, Wang L, Zhang Y, Wei D, Hu Y
Front Oncol. 2025; 15:1441384.
PMID: 40034591
PMC: 11872906.
DOI: 10.3389/fonc.2025.1441384.
β-elemene inhibits tumor-promoting in small cell lung cancer by affecting M2 macrophages and TGF-β.
Huang W, Fu B, Xu H
BMC Pulm Med. 2025; 25(1):97.
PMID: 40022030
PMC: 11869473.
DOI: 10.1186/s12890-025-03533-z.
Identification of prognostic indicator based on hypoxia-related lncRNAs analysis in lung adenocarcinoma.
Zhang J, Kondowe B, Zhang H, Xie X, Song Q, Guo B
Malawi Med J. 2025; 36(3):170-178.
PMID: 40018402
PMC: 11862855.
DOI: 10.4314/mmj.v36i3.3.
Automated Measurement of Coronary Artery Calcifications and Routine Perioperative Blood Tests Predict Survival in Resected Stage I Lung Cancer.
Sabia F, Valsecchi C, Ledda R, Bogani G, Orlandi R, Rolli L
JTO Clin Res Rep. 2025; 6(3):100788.
PMID: 39990140
PMC: 11847048.
DOI: 10.1016/j.jtocrr.2025.100788.
Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.
Greib A, Zhao S, Ploch M, Henricks J, Easterling R, Moodabagil M
Oncoimmunology. 2025; 14(1):2469375.
PMID: 39981683
PMC: 11849934.
DOI: 10.1080/2162402X.2025.2469375.
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR Exon 20 S768I Mutant Lung Adenocarcinoma: A Case Report and Review of the Literature.
Zhu H, Tang H, Peng H, Ding W
Case Rep Oncol. 2025; 18(1):220-230.
PMID: 39980520
PMC: 11813272.
DOI: 10.1159/000543453.
Upregulation of phosphatase and tensin homolog deleted on chromosome ten inhibits lung cancer cell proliferation by suppressing the oncogene polo-like kinase 1 and inducing autophagy.
Jiang W, Wang P, Huang L
Cytojournal. 2025; 22:10.
PMID: 39958887
PMC: 11829310.
DOI: 10.25259/Cytojournal_146_2024.
B-cell signatures characterize the immune landscape and predict LUAD prognosis via the integration of scRNA-seq and bulk RNA-seq.
Xu K, Han D, Fan Z, Li Y, Liu S, Liao Y
Sci Rep. 2025; 15(1):5453.
PMID: 39953119
PMC: 11828960.
DOI: 10.1038/s41598-025-89213-8.
The Detection of Lung Cancer Cell Profiles in Mediastinal Lymph Nodes Using a Hematological Analyzer and Flow Cytometry Method.
Kwiecien I, Rutkowska E, Raniszewska A, Sokolowski R, Bednarek J, Jahnz-Rozyk K
Cancers (Basel). 2025; 17(3).
PMID: 39941799
PMC: 11816154.
DOI: 10.3390/cancers17030431.
miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis.
Mirra D, Esposito R, Spaziano G, Rafaniello C, Panico F, Squillante A
Int J Mol Sci. 2025; 26(3).
PMID: 39941045
PMC: 11818525.
DOI: 10.3390/ijms26031277.
The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by p62-Dependent SIRT6 Degradation.
Kim S, Ki S, Hyeong S, Oh S
Nutrients. 2025; 17(3).
PMID: 39940397
PMC: 11821008.
DOI: 10.3390/nu17030539.
Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinoma.
Fan M, Li M, Zhou J, Li A, Sun Y, Shi P
Mol Biol Rep. 2025; 52(1):225.
PMID: 39937385
DOI: 10.1007/s11033-025-10315-7.
Chronic obstructive pulmonary disease burden attributable to tobacco and the trend change from 1990 to 2021 in China.
Zhang Z, Wang K, Xu G, Zhang R
Tob Induc Dis. 2025; 23.
PMID: 39931132
PMC: 11808299.
DOI: 10.18332/tid/200196.
Comparing survival outcomes of localized tumor destruction, sublobar resection, and pulmonary lobectomy in stage IA non-small cell lung cancer: a study from the SEER database.
Cheng L, Li S, Li X
Eur J Med Res. 2025; 30(1):76.
PMID: 39905529
PMC: 11792346.
DOI: 10.1186/s40001-025-02325-9.
Research on detection methods of related substances and degradation products of the antitumor drug selpercatinib.
Xiang J, Cai L, Wang Q, Zhu Y, Han Y
Front Chem. 2025; 12:1534132.
PMID: 39872362
PMC: 11770003.
DOI: 10.3389/fchem.2024.1534132.